Type I interferons inhibit the generation of tumor-associated macrophages.
about
Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic TargetsThe clinical implications of antitumor immunity in head and neck cancer.Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma.HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cells.Direct effect of dsRNA mimetics on cancer cells induces endogenous IFN-β production capable of improving dendritic cell function.In Vivo Visualizing the IFN-β Response Required for Tumor Growth Control in a Therapeutic Model of Polyadenylic-Polyuridylic Acid Administration.
P2860
Type I interferons inhibit the generation of tumor-associated macrophages.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Type I interferons inhibit the generation of tumor-associated macrophages.
@ast
Type I interferons inhibit the generation of tumor-associated macrophages.
@en
type
label
Type I interferons inhibit the generation of tumor-associated macrophages.
@ast
Type I interferons inhibit the generation of tumor-associated macrophages.
@en
prefLabel
Type I interferons inhibit the generation of tumor-associated macrophages.
@ast
Type I interferons inhibit the generation of tumor-associated macrophages.
@en
P2093
P2860
P1476
Type I interferons inhibit the generation of tumor-associated macrophages.
@en
P2093
Amanda Guth
Debra Kamstock
Lance U'Ren
Steven Dow
P2860
P2888
P304
P356
10.1007/S00262-009-0776-6
P577
2009-10-14T00:00:00Z
P5875
P6179
1010088295